Wave Life Sciences
196 hedge funds and large institutions have $1.06B invested in Wave Life Sciences in 2025 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 83 increasing their positions, 52 reducing their positions, and 20 closing their positions.
164% more call options, than puts
Call options by funds: $4.91M | Put options by funds: $1.86M
65% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 20
60% more repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 52
7% more funds holding
Funds holding: 183 → 196 (+13)
1.28% more ownership
Funds ownership: 84.33% → 85.6% (+1.3%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
33% less capital invested
Capital invested by funds: $1.59B → $1.06B (-$529M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$31.7M |
| 2 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$8.48M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
+$5.24M |
| 4 |
JP Morgan Chase
New York
|
+$5.19M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$5.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$12.6M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$10.6M |
| 3 |
SC
Stempoint Capital
New York
|
-$6.9M |
| 4 |
D.E. Shaw & Co
New York
|
-$6.67M |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$5.8M |
WVE Hedge Fund Activity: Q1 2025 in Review
196 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q1 2025, worth a combined $1.06B — down 33% from $1.59B a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new WVE positions and 20 closed out — a net gain of 13 holders — while 83 added to existing stakes and 52 trimmed.
The largest buyer was Adage Capital Partners, adding an estimated $31.7M. The largest seller was Millennium Management, cutting an estimated $12.6M.
- 196 institutional investors held Wave Life Sciences (WVE) as of Q1 2025, up from 183 in Q4 2024.
- Funds reported $1.06B of Wave Life Sciences stock for Q1 2025, down 33% quarter-over-quarter.
- 33 funds opened new Wave Life Sciences positions in Q1 2025 and 20 closed out, a net change of +13 holders.
- The largest Wave Life Sciences buyer in Q1 2025 was Adage Capital Partners, an estimated $31.7M added.
- The largest Wave Life Sciences seller in Q1 2025 was Millennium Management, an estimated $12.6M sold.
Based on aggregated 13F filings for Q1 2025.